-
7 updates on GLP-1s
Ozempic and other GLP-1 medications are increasingly affecting hospital operations and the U.S. healthcare industry. -
Walmart opens 25 new 'autoimmune-focused' pharmacies
Walmart has opened 25 new autoimmune-focused specialty pharmacies across the U.S. -
HHS, Walgreens partner on 1st decentralized COVID shot trial
Walgreens has received $25 million in federal funding to conduct a decentralized clinical trial on COVID-19 vaccine immunity. -
25-person obesity pill trial earns drugmaker $16.8B
On July 17, Roche published early results from a phase 1 trial of an experimental GLP-1 pill for obesity. That day, the drugmaker gained $16.8 billion in its market value, Bloomberg reported. -
Support grows for expanding pharmacist scopes
Compared to a year prior, more pharmacists, physicians, physician assistants and nurse practitioners agree that pharmacists should have more primary care duties, according to a survey conducted by Surescripts. -
Hikma recalls IV bags
On July 22, Hikma Pharmaceuticals announced a voluntary recall of one lot of intravenous bags after a reported adverse event. -
House criticizes PBMs for pushing patients to higher-priced drugs
An investigation by federal lawmakers found that pharmacy-benefit managers promised to control costs but have instead steered patients toward higher-priced medicines and affiliated pharmacies that reduce patient choice, The Wall Street Journal reported July 23. -
Endo recalls mislabeled drug lot
Endo USA is voluntarily recalling one lot of clonazepam because of mislabeled strength information, the FDA said July 17. -
What 14 pharmacy chiefs will prioritize for the next 6 months
Becker's asked chief pharmacy officers from hospitals and health systems across the U.S. to share their focus for the remainder of the year. -
Pfizer, Valneva inch closer to FDA approval of 1st Lyme disease vaccine
Drugmakers Pfizer and Valneva are one step closer to obtaining FDA approval for what would be the first Lyme disease vaccine after publishing positive results from a phase 3 trial, the companies announced July 17. -
The state of drug shortages: ASHP
The number of ongoing drug shortages has decreased since early 2024, but some fundamental and life-saving therapies remain in short supply. -
Demand for hospital pharmacists dips
The second quarter of 2024 saw about a 5% decrease in hospital pharmacist job postings compared to last year, according to a report from the American Association of Colleges of Pharmacy. -
Memorial Hospital in Wyoming appoints new pharmacy director
Memorial Hospital of Sweetwater County in Rock Springs, Wyo., has tapped Brendan Gemelli, PharmD, as its new pharmacy director. -
Mark Cuban's company to import antibiotic in short supply
The FDA is allowing Mark Cuban Cost Plus Drug Co. to temporarily import a syphilis drug that has been in shortage for more than a year. -
From AI to residencies, ASHP passes 16 new policies
In June, the American Society of Health-System Pharmacists passed 16 policies on topics about artificial intelligence, independent prescribing and safe medication handling. -
Pass rates for 7 pharmacy specialty certifications
Nearly 61,000 active pharmacists are certified by the Board of Pharmacy Specialties for 15 specialties. In March and April, the organization found a 63.9% average all-time pass rate among seven certification exams. -
Rite Aid reports security breach
In early June, an unknown third party impersonated a Rite Aid employee to gain access to its systems, the company said July 15. -
Yale med school, health system roll out Connecticut's 1st mobile pharmacy
Yale Medicine and Yale New Haven Health System, both based in New Haven, Conn., have launched Connecticut's first mobile pharmacy. -
From 'unnecessary expense' to industry leader: Baptist's pharmacy journey
A century ago, Baptist Health didn't have pharmacists — just a boy on a bike. Now, it has a $40 million central pharmacy that utilizes the most automation in the nation. -
ISMP warns about mislabeled IV bag overwraps
A mislabeled overwrap and a difference of two lowercase letters on an intravenous bag have prompted a national alert after a nurse administered the medication and, 15 minutes later, the patient's heart rate slowed.
Page 1 of 50